Correction: Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial

Affiliations

• ¹ NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
• ² Melanoma and Skin Cancer Trials Limited, Melbourne, VIC, Australia.
• ³ Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁴ Division of Surgical Oncology, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ⁵ Faculty of Medicine, Mater Clinical School, University of Queensland, Brisbane, QLD, Australia.
• ⁶ Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
• ⁷ Department of Surgery of Melanoma and Sarcoma, Barretos Cancer Hospital, São Paulo, Brazil.
• ⁸ Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
• ⁹ Mersey and West Lancashire Teaching Hospitals NHS Trust, Prescot, Knowsley, UK.
• ¹⁰ Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
• ¹¹ Institute of Oncology Ljubljana, Zaloska 2, 1000, Ljubljana, Slovenia.
• ¹² Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia.
• ¹³ Translational Research Hub, Poche Centre, Melanoma Institute Australia, The University of Sydney, Wollstonecraft, NSW, Australia.
• ¹⁴ Breast and Melanoma Surgery Unit, Royal North Shore Hospital, St Leonards, NSW, Australia.
• ¹⁵ Mater Hospital, Wollstonecraft, NSW, Australia.
• ¹⁶ NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. rachael.morton@sydney.edu.au.
• ¹⁷ Translational Research Hub, Poche Centre, Melanoma Institute Australia, The University of Sydney, Wollstonecraft, NSW, Australia. rachael.morton@sydney.edu.au.